Report Categories
View AllRecent Articles
View All
Is Precision PDS stock breaking key levels Ticks Up 20260427
What is the longterm thesis for FIGS FIGS stock 3739 pct EPS blowout tops analyst estimates
The opportunity most miss about Perdoceo PRDO Ticks Higher 20260508
Why investors are rethinking Rich Sparkle ANPA Quiet 20260505
Cigna Group Downgraded to Hold by Deutsche Bank Amid MultiYear Portfolio Uncertainty
Kevin Warsh to Be Sworn In as Federal Reserve Chair on Friday Signaling Potential Policy Shift
Google Assistant AI Privacy Concerns Potential Implications for Alphabet and Tech Sector
Tulsi Gabbard Resigns as Director of National Intelligence Citing Husbands Cancer Battle
Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Blocker Effects
Stock Market Records Diverge From Plunging Consumer Confidence
JOYY Q4 2025 Earnings EPS Misses Estimates Amid Widening Losses Shares Slip
RPAY Q1 2026 Earnings Earnings Per Share Surpasses Expectations
SKM Q4 2025 Earnings EPS Miss and Stock Decline Signal Caution
Purple Innovation Inc PRPL Q1 2026 Earnings EPS Meets Estimates with Narrow Beat Shares Edge Lower
Rekor Systems Inc REKR Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges
AYTU Q1 2026 Earnings EPS Misses Estimates by 188 Stock Declines Amid Sparse Disclosure
NOVONIX NVX Rises 429 as Stock Bounces from Support at 069
NetSTREIT NTST Slides Slightly as Support Levels Come into Focus
Nektar Therapeutics NKTR Slips 128 as Shares Approach Key Support Level
Cathay General Bancorp CATY Posts Modest Gain Holds Above Key Support
Sutro Biopharma STRO Rallies 57 Testing Key Resistance Zone Amid Sector Uplift
FibroBiologics Inc FBLG Rallies 57 as Shares Test Key Resistance at 118
BrightSpire Capital BRSP Edges Higher as Shares Hold Above Key Support
Vicor Corporation VICR Surges Over 24 Testing Key Resistance After Powerful Rally
KORE Group Holdings KORE Edges Higher as Shares Test Key Resistance Level
Gain Therapeutics GANX Bounces Back Testing Key Resistance at 187
Grayscale Avalanche Staking ETF GAVA Declines 373 Support Test in Sight